Elisabeth Wynne is a General Surgery resident from Washington University in St. Louis currently completing her research years as a Stanford Biodesign Fellow. She has a background in biomedical engineering from the University of Virginia. She is interested in medical technology innovation, particularly related to general and cardiothoracic surgery.

Honors & Awards

  • Department of Homeland Security Scholar, Department of Homeland Security (2006-2008)
  • Travel Award, American Society of Hematology (2009)
  • Looking to the Future, Society of Thoracic Surgeons (2011)

Boards, Advisory Committees, Professional Organizations

  • Member, American College of Surgeons (2011 - Present)
  • Member, Association of Women Surgeons (2012 - Present)
  • Member, American Medical Association (2008 - 2012)

Professional Education

  • Bachelor of Science, University of Virginia (2008)
  • Doctor of Medicine, University of Virginia (2012)

Stanford Advisors

Community and International Work

  • Pop Wuj, Xela, Guatemala


    Medical Spanish

    Partnering Organization(s)

    University of Virginia

    Populations Served

    Rural and Low Income



    Ongoing Project


    Opportunities for Student Involvement


Research & Scholarship

Current Research and Scholarly Interests

Medical technology innovation by identifying robust needs and concept solutions.


All Publications

  • Biodesign process and culture to enable pediatric medical technology innovation SEMINARS IN PEDIATRIC SURGERY Wall, J., Wynne, E., Krummel, T. 2015; 24 (3): 102-106


    Innovation is the process through which new scientific discoveries are developed and promoted from bench to bedside. In an effort to encourage young entrepreneurs in this area, Stanford Biodesign developed a medical device innovation training program focused on need-based innovation. The program focuses on teaching systematic evaluation of healthcare needs, invention, and concept development. This process can be applied to any field of medicine, including Pediatric Surgery. Similar training programs have gained traction throughout the United States and beyond. Equally important to process in the success of these programs is an institutional culture that supports transformative thinking. Key components of this culture include risk tolerance, patience, encouragement of creativity, management of conflict, and networking effects.

    View details for DOI 10.1053/j.sempedsurg.2015.02.005

    View details for Web of Science ID 000355070600002

    View details for PubMedID 25976143

  • Use of a Left Ventricular Assist Device in Hypertrophic Cardiomyopathy JOURNAL OF CARDIAC SURGERY Wynne, E., Bergin, J. D., Ailawadi, G., Kern, J. A., Kennedy, J. L. 2011; 26 (6): 663-665


    Late stages of hypertrophic cardiomyopathy (HCM) result in medically refractory heart failure. Current treatments include septal myomectomy or alcohol ablation; however, not all patients are eligible for these procedures. We describe the technical aspects of implantation of a HeartMate II left ventricular assist device as a bridge to transplant therapy for a patient with HCM and end-stage heart failure. Pre- and post-operative imaging demonstrates the importance of establishing a functional inflow tract for the device.

    View details for DOI 10.1111/j.1540-8191.2011.01331.x

    View details for Web of Science ID 000298002800029

    View details for PubMedID 22010636

Footer Links:

Stanford Medicine Resources: